RSK2 is also involved in a hematopoietic transformation: when compared to the wild type, knockout mice lacking RSK2 showed much higher survival rate upon induction of myeloma by transplantation of oncogenic bone marrow [22]. The gene discussed is RPS6KA3; the disease is plasma cell myeloma.